NO20055692D0 - Intravenous injection of non-neurotoxic plasminogen activators for the treatment of cerebral stroke - Google Patents

Intravenous injection of non-neurotoxic plasminogen activators for the treatment of cerebral stroke

Info

Publication number: NO20055692D0
Authority: NO; Norway
Prior art keywords: treatment; intravenous injection; plasminogen activators; cerebral stroke; neurotoxic plasminogen
Prior art date: 2003-05-02

Application number

NO20055692A

Other languages

Norwegian (no)

Other versions

NO20055692L (en

NO337485B1 (en

Inventor

Wolf-Dieter Schleuning

Mariola Sohngen

Wolfgang Sohngen

Robert Medcalf

Original Assignee

Paion Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-02

Filing date

2005-12-01

Publication date

2005-12-01

2003-05-06 Priority claimed from PCT/EP2003/004729 external-priority patent/WO2004096267A1/en

2005-12-01 Application filed by Paion Deutschland Gmbh filed Critical Paion Deutschland Gmbh

2005-12-01 Publication of NO20055692D0 publication Critical patent/NO20055692D0/en

2006-01-30 Publication of NO20055692L publication Critical patent/NO20055692L/en

2016-04-25 Publication of NO337485B1 publication Critical patent/NO337485B1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Neurology (AREA)
Diabetes (AREA)
Hematology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Zoology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20055692A 2003-05-02 2005-12-01 Use of a non-neurotoxic plasminogen activator from Desmodus rotundus DSPA-alpha-1, for the preparation of a therapeutic drug for intravenous use in the treatment of cerebral stroke NO337485B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EPPCT/EP2003/004608		2003-05-02
PCT/EP2003/004729 WO2004096267A1 (en)	2003-05-02	2003-05-06	Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
PCT/EP2004/004626 WO2004096268A2 (en)	2003-05-02	2004-04-30	Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke

Publications (3)

Publication Number	Publication Date
NO20055692D0 true NO20055692D0 (en)	2005-12-01
NO20055692L NO20055692L (en)	2006-01-30
NO337485B1 NO337485B1 (en)	2016-04-25

Family

ID=35610451

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055692A NO337485B1 (en)	2003-05-02	2005-12-01	Use of a non-neurotoxic plasminogen activator from Desmodus rotundus DSPA-alpha-1, for the preparation of a therapeutic drug for intravenous use in the treatment of cerebral stroke

Country Status (10)

Country	Link
EP (1)	EP1622639B1 (en)
JP (1)	JP2006525270A (en)
KR (1)	KR101212631B1 (en)
BR (1)	BRPI0409865A (en)
CA (1)	CA2524573A1 (en)
HR (1)	HRP20050903B1 (en)
NO (1)	NO337485B1 (en)
NZ (1)	NZ543367A (en)
PL (1)	PL1622639T3 (en)
WO (1)	WO2004096268A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10153601A1 (en)	2001-11-02	2003-05-22	Paion Gmbh	DSPA for the treatment of stroke
US7759506B2 (en)	2002-02-25	2010-07-20	Diffusion Pharmaceuticals Llc	Bipolar trans carotenoid salts and their uses
DE10342518A1 (en) *	2003-09-12	2005-05-12	Paion Gmbh	Plasminogen activators with reduced lysine binding capacity
US8030350B2 (en)	2005-02-24	2011-10-04	Diffusion Pharmaceuticals Llc	Trans carotenoids, their synthesis, formulation and uses
WO2008022801A1 (en) *	2006-08-25	2008-02-28	Paion Deutschland Gmbh	Method for the manufacture of a medicament for treating hemorrhagic stroke
EP1897554A1 (en) *	2006-08-25	2008-03-12	PAION Deutschland GmbH	Method for the manufacture of a medicament for treating hemorrhagic stroke
CA2683760C (en)	2007-04-13	2015-05-19	Diffusion Pharmaceuticals Llc	Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
HUE053131T2 (en)	2009-06-10	2021-06-28	Nono Inc	Treatment regimes for treatment of neurological disease
JP5787884B2 (en)	2009-06-22	2015-09-30	ディフュージョン・ファーマシューティカルズ・エルエルシー	Diffusion enhancing compounds and their use alone or in combination with thrombolytic agents
JP5823672B2 (en) *	2009-07-27	2015-11-25	国立大学法人新潟大学	Pharmaceutical composition for treating cerebral infarction comprising receptor signaling inhibitor
US8652476B2 (en)	2009-07-27	2014-02-18	Niigata University	Pharmaceutical composition for treating ischemic events
JP5823671B2 (en) *	2009-07-27	2015-11-25	国立大学法人新潟大学	Pharmaceutical composition for the treatment of cerebral infarction comprising immunological preparation
ES2654945T3 (en)	2010-06-02	2018-02-15	Diffusion Pharmaceuticals Llc	Oral formulations of trans bipolar carotenoids
DK3427748T3 (en)	2011-06-24	2022-04-19	Nono Inc	COMBINATION THERAPY AGAINST ICE CREAM
US9241970B2 (en)	2011-12-13	2016-01-26	Nono Inc.	Therapy for subarachnoid hemorrhage and ischemia
CN109152839A (en)	2016-03-24	2019-01-04	扩散药品有限公司	Purposes of the bipolarity trans-carotenoid together with chemotherapy and radiotherapy in treating cancer
US10617756B2 (en)	2017-01-05	2020-04-14	Shimojani, LLC	Drug regimen for treatment of cerebral ischemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI100403B (en) *	1988-07-20	1997-11-28	Schering Ag	Process for Preparation of Glycocylated or Glycocylated Pla Sminogen Activators of Vampire Bats Saliva
NL8902454A (en) *	1989-10-03	1991-05-01	Stichting Centraal Lab	MUTANTS OF THE HUMANE PLASMINOGENIC ACTIVATOR INHIBITOR 1 (PAI-1), THEIR PREPARATION AND USE, AND RECOMBINANT POLYNUCLEOTIDES INCLUDING GENETIC INFORMATION CODING FOR THESE MUTANTS.
DE10153601A1 (en) *	2001-11-02	2003-05-22	Paion Gmbh	DSPA for the treatment of stroke

2004
- 2004-04-30 WO PCT/EP2004/004626 patent/WO2004096268A2/en active Application Filing
- 2004-04-30 CA CA002524573A patent/CA2524573A1/en not_active Abandoned
- 2004-04-30 EP EP04730516A patent/EP1622639B1/en not_active Expired - Lifetime
- 2004-04-30 JP JP2006505347A patent/JP2006525270A/en not_active Withdrawn
- 2004-04-30 NZ NZ543367A patent/NZ543367A/en not_active IP Right Cessation
- 2004-04-30 PL PL04730516T patent/PL1622639T3/en unknown
- 2004-04-30 BR BRPI0409865-0A patent/BRPI0409865A/en not_active IP Right Cessation
- 2004-04-30 KR KR1020057020820A patent/KR101212631B1/en not_active Expired - Fee Related
2005
- 2005-10-17 HR HRP20050903AA patent/HRP20050903B1/en not_active IP Right Cessation
- 2005-12-01 NO NO20055692A patent/NO337485B1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2004096268A3 (en)	2005-04-21
NZ543367A (en)	2010-06-25
WO2004096268A2 (en)	2004-11-11
KR101212631B1 (en)	2012-12-14
NO20055692L (en)	2006-01-30
HRP20050903B1 (en)	2013-11-22
EP1622639B1 (en)	2013-01-16
JP2006525270A (en)	2006-11-09
NO337485B1 (en)	2016-04-25
KR20060020616A (en)	2006-03-06
CA2524573A1 (en)	2004-11-11
HRP20050903A2 (en)	2006-08-31
PL1622639T3 (en)	2013-06-28
EP1622639A2 (en)	2006-02-08
BRPI0409865A (en)	2006-05-16

Publication	Publication Date	Title
NO20055692D0 (en)	2005-12-01	Intravenous injection of non-neurotoxic plasminogen activators for the treatment of cerebral stroke
EP1706010A4 (en)	2011-01-26	POTENCY FOR INTRAVENOUS
DE60333501D1 (en)	2010-09-02	Injection devices with reduced effluent of therapeutic agents
DK1353694T3 (en)	2008-03-25	Combinations of ezetimibe with aspirin for the treatment of vascular conditions
AP2006003525A0 (en)	2006-02-28	Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
DK1663287T3 (en)	2009-11-09	Use of modified cyclosporins for the treatment of HCV diseases
DE60325190D1 (en)	2009-01-22	MAGNETICALLY IMPROVED INJECTION CATHETER
NO20042172L (en)	2004-09-17	Insulin molecule with extended duration of action
IS8142A (en)	2005-11-23	Medication useful for the treatment of pain
ATE497505T1 (en)	2011-02-15	MACROCYCLIC INHIBITORS OF THE NS3 SERINE PROTEASE OF HEPATITIS C VIRUS
AP2005003250A0 (en)	2005-03-31	Heterocyclic substituted piperazines for the treatment of schizophrenia.
AP2009004971A0 (en)	2009-10-31	Inhibitors of serine proteases for the treatment of HCV infections
NO20033203D0 (en)	2003-07-15	Therapeutic heterocyclic compounds
DK1678185T3 (en)	2008-12-08	2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds for the treatment of tuberculosis
WO2007047608A3 (en)	2007-09-20	Fibrin targeted therapeutics
IS6917A (en)	2003-08-18	Epothilone derivatives for the treatment of difficult tumors
EP1626692A4 (en)	2008-12-10	Compounds for the treatment of flaviviridae infections
NO20040760L (en)	2004-02-20	New imidazopyridine compounds with therapeutic effect
DK1492501T3 (en)	2009-04-06	Methods of using lamellar bodies for therapeutic purposes
ZA200703704B (en)	2008-08-27	Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
IL173953A0 (en)	2006-07-05	Plasminogen activators
EP1813596A4 (en)	2010-03-31	PROCESS FOR THE SYNTHESIS OF ALPHA, ALPHA-DIFLUOROAMINE
IS8477A (en)	2006-05-22	Beta-lactam for the treatment of MTK disease
NO20054034D0 (en)	2005-08-30	Procedures for the treatment of hypothyroidism.
NO20022253D0 (en)	2002-05-10	Agent for the treatment of hepatitis C

Legal Events

Date	Code	Title	Description
2017-11-27	MM1K	Lapsed by not paying the annual fees